Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
10/07/26	NOK 0.2760	-0.72%	1,153,297
09/07/26	NOK 0.2780	-0.71%	198,924
08/07/26	NOK 0.2800	-0.71%	1,558,428
07/07/26	NOK 0.2820	-2.76%	750,717
06/07/26	NOK 0.2900	+1.40%	466,198

Real-time Oslo Bors

More quotes

Income Statement and Estimates

More financial data

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Oslo Bors Other stock markets 18:45:00 10/07/2026 +04			5-day change	1st Jan Change
0.2760 ^NOK	-0.72%		-3.50%	-91.53%

07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT

Market Cap	82.28M 8.43M 7.37M 6.8M 6.28M 11.92M 804M 12.12M 81.26M 31.91M 396M 31.65M 30.96M 1.36B	P/E 2026 *	-0.73x	P/E 2027 *	-0.99x
Enterprise Value	118M 12.12M 10.6M 9.78M 9.03M 17.13M 1.16B 17.42M 117M 45.87M 569M 45.5M 44.51M 1.96B	EV / Sales 2026 *	-	EV / Sales 2027 *	24.1x
Free-Float	89.66%	Yield 2026 *	-	Yield 2027 *	-

07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-26	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
05-15	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Lifecare Q1 operating loss NOK 31.5 mln	RE
04-23	Lifecare ASA Approves Board Appointments	CI
03-26	Lifecare ASA Announces Operational Restructuring And Centralization Of Operations	CI
03-26	Lifecare ASA Announces Discontinuation of the Business Operations of Lifecare Germany GmbH	CI
03-26	Lifecare ASA to Close German Operations, Consolidate Activities Under Planned Centralization	MT
03-16	Lifecare Chief Scientific Officer to Step Down	MT
03-14	Andreas Pfützner to Step Down as Chief Scientific Officer of Lifecare ASA	CI

07-02	LIFE: Update on production transfer and longevity programme	AQ
06-26	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU
06-22	LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation	AQ
06-12	Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue	PU
06-10	Lifecare ASA: Mandatory notification of trade	PU

Lifecare ASA Stock

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news : Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Course Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 day	-0.72%
1 week	-3.50%
Current month	-4.50%
1 month	-8.00%
3 months	-33.17%
6 months	-62.60%
Current year	-91.53%

1 week	0.27	0.3
1 month	0.27	0.38
Current year	0.27	2
1 year	0.27	23.5
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Hans Johan Hekland BRD	Director/Board Member	68	08/05/2021
Tone Kvåle BRD	Director/Board Member	57	01/01/2024
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-0.72%	-3.50%	-95.00%	-98.91%	8.43M
LONZA GROUP AG	+0.58%	+2.06%	+3.90%	+10.40%	50.73B
REVOLUTION MEDICINES, INC.	-2.22%	-1.25%	+391.53%	+591.38%	39.73B
IQVIA HOLDINGS INC.	-0.54%	+0.39%	+27.67%	-3.89%	34.69B
BEONE MEDICINES AG	-1.36%	+0.35%	+19.34%	+58.83%	33.21B
CELLTRION, INC.	+1.21%	-4.58%	+3.00%	+37.03%	26.76B
ASCENDIS PHARMA A/S	-1.81%	-1.48%	-	-	16.8B
MEDPACE HOLDINGS, INC.	+0.51%	-3.47%	+66.38%	+125.61%	15.37B
EUROFINS SCIENTIFIC SE	+0.23%	-0.58%	+13.80%	+19.56%	13.78B
ICON PUBLIC LIMITED COMPANY	-0.62%	-3.09%	+11.43%	-29.93%	12.85B
Average	-0.47%	-1.10%	+49.12%	+78.90%	24.39B
Weighted average by Cap.	-0.48%	-0.23%	+82.74%	+126.13%

	2026 *	2027 *
Net sales	-	5M 512K 448K 413K 382K 724K 48.85M 736K 4.94M 1.94M 24.07M 1.92M 1.88M 82.74M
Net income	-86M -8.81M -7.71M -7.11M -6.57M -12.46M -840M -12.67M -84.93M -33.35M -414M -33.08M -32.36M -1.42B	-82M -8.4M -7.35M -6.78M -6.26M -11.88M -801M -12.08M -80.98M -31.8M -395M -31.54M -30.85M -1.36B
Net Debt	36M 3.69M 3.23M 2.98M 2.75M 5.21M 352M 5.3M 35.55M 13.96M 173M 13.85M 13.55M 596M	38M 3.89M 3.41M 3.14M 2.9M 5.5M 371M 5.6M 37.53M 14.74M 183M 14.62M 14.3M 629M